FDA Roundup: October 13, 2023
FDA Roundup: October 13, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-13-2023
FDA Roundup: October 13, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-13-2023
FDA Denies Marketing of Six Flavored Vuse Alto E-Cigarette Products Following Determination They Do Not Meet Public Health Standard
http://www.fda.gov/news-events/press-announcements/fda-denies-marketing-six-flavored-vuse-alto-e-cigarette-products-following-determination-they-do-not
FDA Establishes New Advisory Committee on Digital Health Technologies
http://www.fda.gov/news-events/press-announcements/fda-establishes-new-advisory-committee-digital-health-technologies
FDA Roundup: October 6, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-6-2023
FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders
http://www.fda.gov/news-events/press-announcements/fda-takes-steps-advance-development-novel-therapies-stimulant-use-disorders
FDA Roundup: October 3, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-3-2023
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants
http://www.fda.gov/news-events/press-announcements/fda-authorizes-updated-novavax-covid-19-vaccine-formulated-better-protect-against-currently